CDK12 pathogenic variants

Biomarker type: Germline variant

Gene context: CDK12

Chromosome: 17

Requires pathogenic: True

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations	Biomarkers	Cancer types	Therapies
FDA (1)	CDK12 pathogenic variants	Prostate Adenocarcinoma	Olaparib
FDA (1)	CDK12 pathogenic variants	Prostate Adenocarcinoma	Enzalutamide, Talazoparib